Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Value of Tumor Cell-derived Exosomal miRNA in Early Diagnosis of Gastric Cancer Cachexia

NCT06277986 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06277986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Value of Tumor Cell-derived Exosomal miRNA in Early Diagnosis of Gastric Cancer Cachexia
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2021
Completion date
September 1, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cachexia